|
"hsu chih hung"的相关文件
显示项目 1-25 / 175 (共7页)
1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
| 淡江大學 |
2025-11-21 |
Medium spin FeIII regulating the peroxide selectivity in the heterogeneous oxygen reduction reaction of spin-polarized Fe-TAML complexes
|
Tso, Cheng-Han;Hsu, Chih-Hung;Wang, Jiali;Lin, Po-Yi;Lin, Huang-Teng;Hiraoka, Nozomu;Tsai, Ming-Kang;Chen, Chih-Hsin;Chen, Hao Ming |
| 國立成功大學 |
2022-01-27 |
多水源配水系統操作成本最佳化之研究
|
Hsu, Chih-Hung; 徐志宏 |
| 臺大學術典藏 |
2022-01-14T03:38:07Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin, Zhong-Zhe; Chen, Bang-Bin; Hung, Yi-Ping; HUANG, PO-HSIANG; Shen, Ying-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lee, Rheun-Chuan; Chao, Yee; Chiun Hsu |
| 臺大學術典藏 |
2021-12-16T03:39:19Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T03:25:51Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T02:10:26Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
BANG-BIN CHEN; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-16T02:03:28Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
BANG-BIN CHEN; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:39:40Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:29:31Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-11-25T02:38:28Z |
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
|
Wang, Yulei; Lu, Li-Chun; Guan, Yinghui; MING-CHIH HO; Lu, Shan; Spahn, Jessica; Hsu, Chih-Hung |
| 臺大學術典藏 |
2021-11-24T08:20:52Z |
Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
|
Shao, Yu-Yun; Sun, Nai-Yun; Jeng, Yung-Ming; YAO-MING WU; CHIUN HSU; Hsu, Chih-Hung; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2021-09-09T08:45:43Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
GUO, JHE-CYUAN; Lin, Chen-Yuan; Lin, Chia-Chi; Huang, Ta-Chen; Lien, Ming-Yu; Lu, Li-Chun; Kuo, Hung-Yang; Hsu, Chih-Hung |
| 臺大學術典藏 |
2021-09-09T08:44:01Z |
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
|
Huang, Ta-Chen; Liang, Cher-Wei; Li, Yu-I; GUO, JHE-CYUAN; Lin, Chia-Chi; Chen, Ya-Jhen; Cheng, Ann-Lii; Hsu, Chih-Hung |
| 臺大學術典藏 |
2021-03-22T07:10:10Z |
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
|
Wu, Chih-Horng; Liang, Po-Chin; Hsu, Chih-Hung; Chang, Fang-Tsu; Shao, Yu-Yun; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-03-22T02:56:54Z |
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
|
CHIH-HORNG WU; Liang, Po-Chin; Hsu, Chih-Hung; Chang, Fang-Tsu; Shao, Yu-Yun; Ting-Fang Shih, Tiffany |
| 臺大學術典藏 |
2020-04-09T10:33:05Z |
Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure
|
Liu, Tsung Hao; Hsu, Chih Hung; YU-YUN SHAO |
| 臺大學術典藏 |
2020-04-09T09:43:48Z |
Right or left? Side selection for a totally implantable vascular access device: A randomised observational study
|
Lin, Wen Ying; Lin, Chih Peng; Hsu, Chih Hung; Lee, Ying Hui; Lin, Yi Ting; Hsu, Meng Chi; Shao, Yu Yun |
| 臺大學術典藏 |
2020-04-09T09:38:50Z |
Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma
|
Shao, Yu-Yun; Liu, Tsung-Hao; Lee, Ying-Hui; Hsu, Chih-Hung; Cheng, Ann-Lii |
| 臺大學術典藏 |
2020-04-09T09:34:35Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Cheng, Ann Lii;Hsu, Chih Hung;Lin, Zhong Zhe;Hsu, Chiun;Shen, Ying Chun;Lu, Li Chun;Shao, Yu Yun;Liu, Tsung Hao; Liu, Tsung Hao; Shao, Yu Yun; Lu, Li Chun; Shen, Ying Chun; Hsu, Chiun; Lin, Zhong Zhe; Hsu, Chih Hung; Cheng, Ann Lii |
| 臺大學術典藏 |
2020-04-09T09:33:46Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu, Chih Hung;Huang, Ta Chen;Shao, Yu Yun;Lien, Ming Yu;Kuo, Hung Yang;Hsieh, Min Shu;Lin, Chen Yuan;Lin, Chia Chi;Guo, Jhe Cyuan; Guo, Jhe Cyuan; Lin, Chia Chi; Lin, Chen Yuan; Hsieh, Min Shu; Kuo, Hung Yang; Lien, Ming Yu; Shao, Yu Yun; Huang, Ta Chen; Hsu, Chih Hung |
| 臺大學術典藏 |
2020-04-09T09:32:14Z |
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
|
Shao, Yu Yun; Hsieh, Min Shu; Wang, Han Yu; Li, Yong Shi; Lin, Hang; Hsu, Hung Wei; Huang, Chung Yi; Hsu, Chih Hung; Cheng, Ann Lii |
| 國立交通大學 |
2019-12-13T01:12:16Z |
Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network
|
Tsai, Ping-Hsing; Chien, Yueh; Wang, Mong-Lien; Hsu, Chih-Hung; Laurent, Benoit; Chou, Shih-Jie; Chang, Wei-Chao; Chien, Chian-Shiu; Li, Hsin-Yang; Lee, Hsin-Chen; Huo, Teh-Ia; Hung, Jui-Hung; Chen, Chung-Hsuan; Chiou, Shih-Hwa |
| 國立臺灣師範大學 |
2019-09-06T01:01:53Z |
八首貝利尼室內聲樂作品研究
|
徐智宏; Hsu Chih-Hung |
| 國立交通大學 |
2019-04-03T06:44:03Z |
Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3
|
Chen, Hsiao-Yun; Lin, Liang-Ting; Wang, Mong-Lien; Laurent, Benoit; Hsu, Chih-Hung; Pan, Chih-Ming; Jiang, Wan-Ru; Chen, Pau-Yuan; Ma, Hsin-I; Chen, Yi-Wei; Huang, Pin-I; Chiou, Arthur; Chiou, Shih-Hwa |
| 臺大學術典藏 |
2019-03-01 |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Hsu, Chih Hung; Cheng, Ann Lii; Liu, Tsung Hao; Shao, Yu Yun; Fang, Chih Yeu; Shun, Chia Tung; Hsu, Chih Hung;Cheng, Ann Lii;Liu, Tsung Hao;Shao, Yu Yun;Fang, Chih Yeu;Shun, Chia Tung;Chang, Chun Jung;Lee, Yi Hsuan;Lu, Li Chun; Lu, Li Chun; Lee, Yi Hsuan; Chang, Chun Jung |
显示项目 1-25 / 175 (共7页)
1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
|
